The Product

Byonyks X1 Device

Starting in 2025, Byonyks will be treating patients in the U.S within their own homes, without needles, without drawing blood in the comfort of their homes. Patients will have an active lifestyle, and they can work during the treatment.

Byonyks X2 & X3 Device

The combination of these two devices will truly revolutionize peritoneal dialysis and disrupt the market by delivering ultra-pure, biocompatible, non-inflammatory dialysis solutions with devices that are patient-friendly. Doing so will improve patient outcomes by reducing proven inflammatory mediators, allowing glucose & bicarbonate concentrations to be customized, and providing innovative ways to reduce the risk of peritonitis.  It will also be very eco friendly by significantly reducing the amount of plastic medical waste typically generated by home PD systems.